Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.
Nucleic Acids Research|November 11, 2020
MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotationsSneha Rath, Rohit Sharma, Rahul Gupta, et al.
Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.
Lancet (London, England)|July 5, 2016
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Jennifer Wellman, Kathleen A Marshall, et al.
Nature Medicine|January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
The New England Journal of Medicine|September 1, 2006
Celecoxib for the prevention of sporadic colorectal adenomasMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Trials|February 2, 2017
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trialDavid A Drew, Samantha M Chin, Katherine K Gilpin, et al.
Nature Medicine|September 11, 2019
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Dawn Provenzale, Xavier Llor, et al.
Nature Medicine|July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Pageof 19